Cell-free circulating tumor DNA in cancer
Abstract Cancer is a common cause of death worldwide. Despite significant advances in cancer treatments, the morbidity and mortality are still enormous. Tumor heterogeneity, especially intratumoral heterogeneity, is a significant reason underlying difficulties in tumor treatment and failure of a num...
Main Authors: | Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong, Jimin Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-04-01
|
Series: | Chinese Journal of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-016-0092-4 |
Similar Items
-
Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
by: Wei Zhang, et al.
Published: (2017-02-01) -
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01) -
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Jie Li, et al.
Published: (2018-09-01) -
Circulating tumor DNA as a marker of residual tumor in colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2018-11-01) -
Clinical applications and perspectives of circulating tumor DNA in gastric cancer
by: Jing-Han Li, et al.
Published: (2024-01-01)